Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to the pharmaceutical company. The nasal spray can be given to people who haven’t seen improvements ...

J&J on Tuesday said the green light makes Spravato the first and only monotherapy for adults with major depressive disorder who have had an inadequate response to at least two oral antidepressants.

Sepsis, the leading cause of death in U.S. hospitals killing about 350,000 people annually, is an extreme response to an ...

Using a simple blood draw, the TriVerity system spits out three scores to ER personnel within 30 minutes that determine if ...

The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...

It turns out, your protein powder might not be as healthy as you think.A new report from the Clean Label Project revea ...

Made from petroleum and chemically known as erythrosine, red dye No. 3 is a synthetic color additive used to give foods and ...

New Jersey has considered legislation that would ban the sale of smoke free nicotine pouches, following in the footsteps of ...

No. 13 Oregon will seek its first home win over a Top 25 team this season on Saturday afternoon against No. 17 Purdue in a ...

The Texas judge who previously halted approval of the nation’s most common method of abortion ruled Thursday that three ...

This week, the Food and Drug Administration announced a nationwide ban on “red Dye 3,” a food additive with possible links to ...

We should celebrate this step, but our efforts must continue,” Sen. Kristen Thompson said. “There are still a number of ...